Competing targets of microRNA-608 affect anxiety and hypertension

Human Molecular Genetics

Volumn 23, Issue 17, 2014, Pages 4569-4580

  Hanin, Geula ^a   Shenhar Tsarfaty, Shani ^a   Yayon, Nadav ^a   Hoe, Yau Yin ^b   Bennett, Estelle R ^a   Sklan, Ella H ^c   Rao, Dabeeru C ^d   Rankinen, Tuomo ^e   Bouchard, Claude ^e   Geifman Shochat, Susana ^b   Shifman, Sagiv ^a   Greenberg, David S ^a   Soreq, Hermona ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^c TEL AVIV UNIVERSITY   (Israel)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; HYDROCORTISONE; INTERLEUKIN 6; MICRORNA; MICRORNA 608; PROTEIN CDC42; UNCLASSIFIED DRUG; MIRN608 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ALLELE; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BRAIN CORTEX; CARDIOVASCULAR RISK; CELL CULTURE; CONTROLLED STUDY; ELEVATED BLOOD PRESSURE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; INTERACTIONS WITH RNA; MOUSE; NONHUMAN; PRIMATE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; BLOOD; BLOOD PRESSURE; BRAIN; C57BL MOUSE; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; METABOLISM; MOLECULAR GENETICS; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; SPECIES DIFFERENCE;

ACETYLCHOLINESTERASE; ALLELES; ANIMALS; ANXIETY; BASE SEQUENCE; BLOOD PRESSURE; BRAIN; CDC42 GTP-BINDING PROTEIN; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEALTHY VOLUNTEERS; HETEROZYGOTE; HOMOZYGOTE; HUMANS; HYDROCORTISONE; HYPERTENSION; INTERLEUKIN-6; MALE; MICE, INBRED C57BL; MICRORNAS; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; PRIMATES; SPECIES SPECIFICITY;

EID: 84905645822     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu170     Document Type: Article

References (55)

1. Bartel, D.P. (2009)MicroRNAs: target recognition and regulatory functions. Cell, 136, 215-233.
2. Lau, P. and de Strooper, B. (2010) Dysregulated microRNAs in neurodegenerative disorders. Semin. Cell. Dev. Biol., 21, 768-773.
3. Filipowicz, W., Bhattacharyya, S.N. and Sonenberg, N. (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. rev. Genet., 9, 102-114.
4. Shaked, I., Meerson, A.,Wolf, Y., Avni, R., Greenberg, D., Gilboa-Geffen, A. and Soreq, H. (2009)MicroRNA-132potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. Immunity, 31, 965-973.
5. Soreq, H. and Wolf, Y. (2011) NeurimmiRs: microRNAs in the neuroimmune interface. Trends Mol. Med., 17, 548-555.
6. Abelson, J.F., Kwan, K.Y., O'Roak, B.J., Baek, D.Y., Stillman, A.A., Morgan, T.M., Mathews, C.A., Pauls, D.L., Rasin, M.R., Gunel, M. et al. (2005) Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science, 310, 317-320.
7. Martin, M.M., Buckenberger, J.A., Jiang, J., Malana, G.E., Nuovo, G.J., Chotani, M., Feldman, D.S., Schmittgen, T.D. and Elton, T.S. (2007) The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microrna-155 binding. J. Biol. Chem., 282, 24262-24269.
8. Poliseno, L., Salmena, L., Zhang, J., Carver, B., Haveman, W.J. and Pandolfi, P.P. (2010) A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature, 465, 1033-1038.
9. Salmena, L., Poliseno, L.,Tay,Y., Kats, L. and Pandolfi, P.P. (2011)AceRNA hypothesis: theRosettaStone of a hiddenRNAlanguage?Cell, 146, 353-358.
10. Tay, Y., Rinn, J. and Pandolfi, P.P. (2014) The multilayered complexity of ceRNA crosstalk and competition. Nature, 505, 344-352.
11. Franco-Zorrilla, J.M., Valli, A., Todesco, M., Mateos, I., Puga, M.I., Rubio-Somoza, I., Leyva, A., Weigel, D., Garcia, J.A. and Paz-Ares, J. (2007) Target mimicry provides a new mechanism for regulation of microRNA activity. Nat. Genet., 39, 1033-1037.
12. Lau, P., Bossers, K., Salta, E., Sala Frigerio, C., Janky, R., Barbash, S., Rothman, R., Sierksma, A., Thathiah, A., Greenberg, D.S. et al. (2013) Alteration of the microRNA network during the progression of Alzheimer's disease. Embo Mol. Med., 5, 1613-1634.
13. Maharshak, N., Shenhar-Tsarfaty, S., Aroyo, N., Orpaz, N., Guberman, I., Canaani, J., Halpern, Z., Dotan, I., Berliner, S. and Soreq, H. (2013) MicroRNA-132 modulates cholinergic signaling and inflammation in human inflammatory bowel disease. Inflamm. Bowel. Dis., 19, 1346-1353.
14. Shaltiel, G., Hanan, M., Wolf, Y., Barbash, S., Kovalev, E., Shoham, S. and Soreq, H. (2013) Hippocampal microRNA-132 mediates stress-inducible cognitive deficits through its acetylcholinesterase target. Brain Struct. Funct., 218, 59-72.
15. Ryan, B.M., McClary, A.C., Valeri, N., Robinson, D., Paone, A., Bowman, E.D., Robles, A.I., Croce, C. and Harris, C.C. (2012) rs4919510 in hsa-mir-608 is associated with outcome but not risk of colorectal cancer. PLoS ONE, 7, e36306.
16. Haramati, S., Navon, I., Issler, O., Ezra-Nevo, G., Gil, S., Zwang, R., Hornstein, E. and Chen, A. (2011)MicroRNAas repressors of stress-induced anxiety: the case of amygdalar miR-34. J. Neurosci., 31, 14191-14203.
17. Mineur, Y.S., Obayemi, A., Wigestrand, M.B., Fote, G.M., Calarco, C.A., Li, A.M. and Picciotto, M.R. (2013) Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behavior. Proc. Natl. Acad. Sci. USA, 110, 3573-3578.
18. Hasin, Y., Avidan, N., Bercovich, D., Korczyn, A., Silman, I., Beckmann, J.S. and Sussman, J.L. (2004) A paradigm for single nucleotide polymorphism analysis: the case of the acetylcholinesterase gene. Hum. Mutat., 24, 408-416.
19. Jeyapalan, Z., Deng, Z., Shatseva, T., Fang, L., He, C. and Yang, B.B. (2011) Expression of CD44 3'-untranslated region regulates endogenous microRNA functions in tumorigenesis and angiogenesis. Nucl. Acids Res., 39, 3026-3041.
20. Kang, J.G., Majerciak, V., Uldrick, T.S., Wang, X., Kruhlak, M., Yarchoan, R. and Zheng, Z.M. (2011) Kaposi's sarcoma-associated herpesviral IL-6 and human IL-6 open reading frames contain miRNA binding sites and are subject to cellular miRNA regulation. J. Pathol., 225, 378-389.
21. Hanin, G. and Soreq, H. (2011) Cholinesterase-targeting microRNAs Identified in silico affect specific biological processes. Frontiers Mol. Neurosci., 4, 28.
22. Homola, J. (2008) Surface plasmon resonance sensors for detection of chemical and biological species. Chem. Rev., 108, 462-493.
23. Zhang, Y., Cheng, Y., Ren, X., Zhang, L., Yap, K.L., Wu, H., Patel, R., Liu, D., Qin, Z.H., Shih, I.M. et al. (2012)NAC1modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response. Oncogene, 31, 1055-1064.
24. Guhaniyogi, J., Sohar, I., Das, K., Stock, A.M. and Lobel, P. (2009) Crystal structure and autoactivation pathway of the precursor form of human tripeptidyl-peptidase 1, the enzyme deficient in late infantile ceroid lipofuscinosis. J. Biol. Chem., 284, 3985-3997.
25. Papadopoulos, T., Korte, M., Eulenburg, V., Kubota, H., Retiounskaia, M., Harvey, R.J., Harvey, K., O'Sullivan, G.A., Laube, B., Hulsmann, S. et al. (2007) ImpairedGABAergic transmission and altered hippocampal synaptic plasticity in collybistin-deficient mice. EMBO J., 26, 3888-3899.
26. Vallieres, L., Campbell, I.L., Gage, F.H. and Sawchenko, P.E. (2002) Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6. J. Neurosci., 22, 486-492.
27. Raison, C.L. and Miller, A.H. (2012) The evolutionary significance of depression in pathogen host defense (PATHOS-D). Mol. Psychiatry, 18, 15-37.
28. Berson, A., Barbash, S., Shaltiel, G., Goll, Y., Hanin, G., Greenberg, D.S., Ketzef, M., Becker, A.J., Friedman, A. and Soreq, H. (2012) Cholinergicassociated loss of hnRNP-A/B in Alzheimer's disease impairs cortical splicing and cognitive function in mice. EMBO Mol. Med., 4, 730-742.
29. Podoly, E., Shalev, D.E., Shenhar-Tsarfaty, S., Bennett, E.R., Ben Assayag, E., Wilgus, H., Livnah, O. and Soreq, H. (2009) The butyrylcholinesteraseK variant confers structurally derived risks for Alzheimer pathology. J. Biol. Chem., 284, 17170-17179.
30. Pavlov, V.A., Parrish, W.R., Rosas-Ballina, M., Ochani, M., Puerta, M., Ochani, K., Chavan, S., Al-Abed, Y. and Tracey, K.J. (2009) Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Brain Behav. Immun., 23, 41-45.
31. Rosas-Ballina, M., Olofsson, P.S., Ochani, M., Valdes-Ferrer, S.I., Levine, Y.A., Reardon, C., Tusche, M.W., Pavlov, V.A., Andersson, U., Chavan, S. et al. (2011) Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science, 334, 98-101.
32. O'Donovan, A., Hughes, B.M., Slavich, G.M., Lynch, L., Cronin, M.T., O'Farrelly, C. and Malone, K.M. (2010) Clinical anxiety, cortisol and interleukin-6: evidence for specificity in emotion-biology relationships. Brain Behav. Immun., 24, 1074-1077.
33. Kaufer, D., Friedman, A., Seidman, S. and Soreq, H. (1998) Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature, 393, 373-377.
34. Tyagarajan, S.K., Ghosh, H., Harvey, K. and Fritschy, J.M. (2011) Collybistin splice variants differentially interact with gephyrin and Cdc42 to regulate gephyrin clustering at GABAergic synapses. J. Cell Sci., 124, 2786-2796.
35. Guyenet, P.G. (2006) The sympathetic control of blood pressure. Nat. Rev. Neurosci., 7, 335-346.
36. Sklan, E.H., Lowenthal, A., Korner, M., Ritov, Y., Landers, D.M., Rankinen, T., Bouchard, C., Leon, A.S., Rice, T., Rao, D.C. et al. (2004) Acetylcholinesterase/paraoxonase genotype and expression predict anxiety scores in Health, Risk Factors, Exercise Training, and Genetics study. Proc. Natl. Acad. Sci. USA, 101, 5512-5517.
37. Gershon, E.S., Badner, J.A., Goldin, L.R., Sanders, A.R., Cravchik, A. and Detera-Wadleigh, S.D. (1998) Closing in on genes for manic-depressive illness and schizophrenia. Neuropsychopharmacology, 18, 233-242.
38. Miwa, J.M., Freedman, R. and Lester, H.A. (2011) Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses. Neuron, 70, 20-33.
39. Yehuda, R. and Seckl, J. (2011) Minireview: stress-related psychiatric disorders with low cortisol levels: a metabolic hypothesis. Endocrinology, 152, 4496-4503.
40. Ong, K.L., Cheung, B.M., Man, Y.B., Lau, C.P. and Lam, K.S. (2007) Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension, 49, 69-75.
41. Lettre, G., Palmer, C.D., Young, T., Ejebe, K.G., Allayee, H., Benjamin, E.J., Bennett, F., Bowden, D.W., Chakravarti, A., Dreisbach, A. et al. (2011) Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project. PLoS Genet., 7, e1001300.
42. Martin-Granados, C., Prescott, A.R., Van Dessel, N., Van Eynde, A., Arocena, M., Klaska, I.P., Gornemann, J., Beullens, M., Bollen, M., Forrester, J.V. et al. (2012) A role for PP1/NIPP1 in steering migration of human cancer cells. PLoS ONE, 7, e40769.
43. Barbash, S., Shifman, S. and Soreq, H. (In Press) Global co-evolution of human microRNAs and their target genes. Mol. Biol. Evol., doi:10.1093/ molbev/msu090.
44. Nadorp, B. and Soreq, H. (2014) Predicted overlapping microRNA regulators of acetylcholine packaging and degradation in neuroinflammation-related disorders. Frontiers Mol. Neurosci., 7, in press.
45. Akiguchi, I. and Yamamoto, Y. (2010) Vascular mechanisms of cognitive impairment: roles of hypertension and subsequent small vessel disease under sympathetic influences. Hypertens Res., 33, 29-31.
46. McEwen, B.S. and Gianaros, P.J. (2011) Stress- and allostasis-induced brain plasticity. Annu. Rev. Med., 62, 431-445.
47. Deter, H.C., Micus, C., Wagner, M., Sharma, A.M. and Buchholz, K. (2006) Salt sensitivity, anxiety, and irritability predict blood pressure increase over five years in healthy males. Clin. Exp. Hypertens, 28, 17-27.
48. Schneider, G.M., Jacobs, D.W., Gevirtz, R.N. and O'Connor, D.T. (2003) Cardiovascular haemodynamic response to repeated mental stress in normotensive subjects at genetic risk of hypertension: evidence of enhanced reactivity, blunted adaptation, and delayed recovery. J. Hum. Hypertens, 17, 829-840.
49. Gianaros, P.J., Onyewuenyi, I.C., Sheu, L.K., Christie, I.C. and Critchley, H.D. (2012) Brain systems for baroreflex suppression during stress in humans. Hum. Brain Mapp., 33, 1700-1716.
50. Gianaros, P.J., Sheu, L.K., Remo, A.M., Christie, I.C., Crtichley, H.D. and Wang, J. (2009) Heightened resting neural activity predicts exaggerated stressor-evoked blood pressure reactivity. Hypertension, 53, 819-825.
51. Jennings, J.R. and Zanstra, Y. (2009) Is the brain the essential in hypertension? Neuroimage, 47, 914-921.
52. Stranahan, A.M. and Mattson, M.P. (2012)Recruiting adaptive cellular stress responses for successful brain ageing. Nat. Rev. Neurosci., 13, 209-216.
53. Ofek, K., Krabbe, K.S., Evron, T., Debecco, M., Nielsen, A.R., Brunnsgaad, H., Yirmiya, R., Soreq, H. and Pedersen, B.K. (2007) Cholinergic status modulations in human volunteers under acute inflammation. J. Mol. Med. (Berl), 85, 1239-1251.
54. Peritz, T., Zeng, F., Kannanayakal, T.J., Kilk, K., Eiriksdottir, E., Langel, U. and Eberwine, J. (2006) Immunoprecipitation of mRNA-protein complexes. Nat. Protoc., 1, 577-580.
55. Barbash, S., Hanin, G. and Soreq, H. (2013) Stereotactic injection of microRNA-expressing lentiviruses to the mouse hippocampus ca1 region and assessment of the behavioral outcome. J. Vis. Exp., 76, e50170.